SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-200883
Filing Date
2012-05-01
Accepted
2012-05-01 16:25:37
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d324632d10q.htm 10-Q 636005
2 AMENDMENT TO THE INTERMEDIATE SUPPLY AGREEMENT d324632dex101.htm EX-10.1 12979
3 SECTION 302 CEO CERTIFICATION d324632dex311.htm EX-31.1 9650
4 SECTION 302 CFO CERTIFICATION d324632dex312.htm EX-31.2 9640
5 SECTION 906 CEO AND CFO CERTIFICATION d324632dex321.htm EX-32.1 4651
  Complete submission text file 0001193125-12-200883.txt   5965644

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vphm-20120331.xml EX-101.INS 815351
7 XBRL TAXONOMY EXTENSION SCHEMA vphm-20120331.xsd EX-101.SCH 53111
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vphm-20120331_cal.xml EX-101.CAL 51396
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vphm-20120331_def.xml EX-101.DEF 195706
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vphm-20120331_lab.xml EX-101.LAB 477339
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vphm-20120331_pre.xml EX-101.PRE 385311
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 12801011
SIC: 2834 Pharmaceutical Preparations